Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13844
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrachayasittikul V.
dc.contributor.authorPingaew R.
dc.contributor.authorWorachartcheewan A.
dc.contributor.authorNantasenamat C.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:32:30Z-
dc.date.available2021-04-05T03:32:30Z-
dc.date.issued2014
dc.identifier.issn2235234
dc.identifier.other2-s2.0-84904286268
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13844-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84904286268&doi=10.1016%2fj.ejmech.2014.07.024&partnerID=40&md5=26f698afea0572dcde64dca8e646d261
dc.description.abstractA series of 2-substituted amino-3-chloro-1,4-naphthoquinone derivatives (3-12) were synthesized as anticancer agents and tested against four cancer cell lines including HepG2, HuCCA-1, A549 and MOLT-3. The most potent cytotoxic activity against the HepG2, HuCCA-1 and A549 cell lines was found to be m-acetylphenylamino-1,4-naphthoquinone (8) affording IC50 values of 4.758, 2.364 and 12.279 μM, respectively. On the other hand, p-acetylphenylamino-1,4-naphthoquinone (9) exhibited the most potent cytotoxic activity against the MOLT-3 cell line with an IC50 of 2.118 μM. Quantitative structure-activity relationship (QSAR) investigations provided good predictive performance as observed from cross-validated R of 0.9177-0.9753 and RMSE of 0.0614-0.1881. The effects of substituents at the 2-amino position on the naphthoquinone core structure and its corresponding influence on the cytotoxic activity were investigated by virtually constructing additional 1,4-naphthoquinone compounds (13-36) for which cytotoxic activities were predicted using equations obtained from the previously constructed QSAR models. Interpretation of informative descriptors from QSAR models revealed pertinent knowledge on physicochemical properties governing the cytotoxic activities of tested cancer cell lines. It is anticipated that the QSAR models developed herein could provide guidelines for further development of novel and potent anticancer agents. © 2014 Published by Elsevier Masson SAS.
dc.subject1,4 naphthoquinone derivative
dc.subject2 (2 chloro 1,4 dihydro 1,4 dioxonaphthalen 3 ylamino) benzoic acid
dc.subject2 (3 acetylphenylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 (3,4 dimethoxyphenethylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 (4 acetylphenylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 (n butylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 (n methyl n phenylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 chloro 3 (phenethylamino)naphthalene 1,4 dione
dc.subject2 chloro 3 (phenylamino)naphthalene 1,4 dione
dc.subject2 chloro 3 [[4 (phenylamino)phenyl]amino] naphthalene 1,4 dione
dc.subjectcytotoxic agent
dc.subjectdoxorubicin
dc.subjectetoposide
dc.subjectunclassified drug
dc.subject1,4 naphthoquinone derivative
dc.subject2 (2 chloro 1,4 dihydro 1,4 dioxonaphthalen 3 ylamino)benzoic acid
dc.subject2 (3 acetylphenylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 (3,4 dimethoxyphenethylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 (4 acetylphenylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 (n butylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 (n methyl n phenylamino) 3 chloronaphthalene 1,4 dione
dc.subject2 chloro 3 (phenethylamino)naphthalene 1,4 dione
dc.subject2 chloro 3 (phenylamino)naphthalene 1,4 dione
dc.subject2 chloro 3 (quinolin 8 ylamino)naphthalene 1,4 dione
dc.subject2 chloro 3 [(4 (phenylamino)phenyl)amino] naphthalene 1,4 dione
dc.subjectcytotoxic agent
dc.subjectdoxorubicin
dc.subjectetoposide
dc.subjectreactive oxygen metabolite
dc.subject1,4-naphthoquinone
dc.subjectantineoplastic agent
dc.subjectnaphthoquinone
dc.subjectantineoplastic activity
dc.subjectantiproliferative activity
dc.subjectarticle
dc.subjectcarbon nuclear magnetic resonance
dc.subjectdrug potency
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectfemale
dc.subjectHepG2 cell line
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC 50
dc.subjectlipophilicity
dc.subjectnucleophilicity
dc.subjectphysical chemistry
dc.subjectproton nuclear magnetic resonance
dc.subjectquantitative structure activity relation
dc.subjectstereospecificity
dc.subjectsubstitution reaction
dc.subjectA549 cell line
dc.subjectalkylation
dc.subjectArticle
dc.subjectbase pairing
dc.subjectcell viability
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectdipole
dc.subjectDNA cleavage
dc.subjectDNA damage
dc.subjectDNA denaturation
dc.subjectDNA strand breakage
dc.subjectdrug conformation
dc.subjectdrug cytotoxicity
dc.subjectelectrophilicity
dc.subjectembryo
dc.subjectenzyme active site
dc.subjectIC50
dc.subjectoxidation reduction potential
dc.subjectvalidation study
dc.subjectcell line
dc.subjectcell proliferation
dc.subjectchemical structure
dc.subjectchemistry
dc.subjectdose response
dc.subjectdrug effects
dc.subjectdrug screening
dc.subjectsynthesis
dc.subjectAntineoplastic Agents
dc.subjectCell Line
dc.subjectCell Proliferation
dc.subjectDose-Response Relationship, Drug
dc.subjectDrug Screening Assays, Antitumor
dc.subjectHep G2 Cells
dc.subjectHumans
dc.subjectMolecular Structure
dc.subjectNaphthoquinones
dc.subjectQuantitative Structure-Activity Relationship
dc.titleSynthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationEuropean Journal of Medicinal Chemistry. Vol 84, (2014), p.247-263
dc.identifier.doi10.1016/j.ejmech.2014.07.024
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.